Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expanding the criteria for BRCA mutation testing in breast cancer survivors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Sept 2010

Kwon Janice S, Gutierrez-Barrera Angelica M, Young Diana, Sun Charlotte C, Daniels Molly S, Lu Karen H, Arun Banu

Abstract excerpt

PURPOSE: Every year approximately 25% of women diagnosed with breast cancer are younger than 50 years of age, and almost 10% of them have a BRCA mutation. Not all potential carriers are identified by existing criteria for BRCA testing. We estimated the costs and benefits of different BRCA testing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Health Care Costs
Share to Life Expectancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Models, Economic

Share to Monte Carlo Method

Share to Patient Selection

Share to Practice Guidelines as Topic

Share to Quality-Adjusted Life Years

Source

Identifiers

PMID: 20733129
DOI: 10.1200/JCO.2010.28.0719

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20733129-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expanding the criteria for BRCA mutation testing in breast cancer survivors.PMID 20733129Read ↗

Preventing future cancers by testing women with ovarian cancer for BRCA mutations.Semantic proximity Read ↗

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.Semantic proximity Read ↗

Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.Semantic proximity Read ↗

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years.Semantic proximity Read ↗

Assessing the effectiveness of NICE criteria for stratifying breast cancer risk in a UK cohort.Semantic proximity Read ↗

Cost-effectiveness of testing for breast cancer susceptibility genes.Semantic proximity Read ↗

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.Semantic proximity Read ↗

Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: a decision analysis.Semantic proximity Read ↗

Rates of BRCA1/2 mutation testing among young survivors of breast cancer.Semantic proximity Read ↗

Estimating the survival benefits gained from providing national cancer genetic services to women with a family history of breast cancer.Semantic proximity Read ↗

Monte Carlo Tree Search for optimal cancer intervention strategies among BRCA mutation carriers.Semantic proximity Read ↗

Preimplantation genetic testing for BReast CAncer gene 1 and risk-reducing surgery is more effective at age 35 than age 40.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.